 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jul 05, 2023 |
| Title |
Combined CRISPR and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression [gRNA] |
| Organisms |
Homo sapiens; Expression vector lentiGuide-Puro |
| Experiment type |
Other
|
| Summary |
Introduction Genome-wide association studies along with expression quantitative trait loci (eQTL) have identified hundreds of single nucleotide polymorphisms (SNPs) and their target genes in prostate cancer (PrCa). Although these genetic associations to PrCa have been widely reported, functional characterization of these risk loci remains challenging. Methods To screen for regulatory SNPs, we designed a library containing 9133 guide RNAs (gRNAs) to target 2,166 candidate SNP sites implicated in PrCa. We performed negative screening in dCas9-KRAB stable prostate cell lines and applied the RIGOR program to identify the essential SNPs for cell proliferation. We further characterized the regulatory role of a selected single nucleotide polymorphim (SNP, rs60464856) using luciferase reporter assay, ChIP-qPCR, and xCas9 base editing in prostate cells. Finally, we investigated the biological impact of the SNP-regulated gene RUVBL1 on cell proliferation and tumor growth via gene knockdown using in vitro and in vivo assays. Results From interference of 2,166 candidate SNPs via CRISPR interference screening, the RIGOR program identified 117 SNPs that could regulate genes to promote growth advantage in prostate cancer cell lines. Compared to unselected SNPs, the 117 candidates tended to reside near 5 kb flanking the transcription start sites (p = 0.01). To characterize the regulatory role of these SNPs, we selected one SNP (rs60464856) for detailed analysis. This SNP was covered by multiple gRNAs significantly depleted in the screening (FDR<0.05). Pooled SNP association analysis in the PRACTICAL cohort showed significantly higher PrCa risk for the G allele (pvalue=1.2E-16). eQTL analysis showed that the G allele is associated with an increased expression of RUVBL1 in multiple datasets. To further validate the CRISPR interference effect, we transfected a gRNA targeting the rs60464856 site in the dCas9 stable cell lines and observed significant inhibition of the RUVBL1 expression. We also applied the xCas9 adenine base editor to convert the rs60464856 A into G allele and observed an increased RUVBL1 expression in subclones carrying the rs60464856 G allele in prostate cell lines. To test if any protein showed allele-specific binding at rs60464856, we used SILAC-based DNA pull-down proteomics and observed that cohesin subunits (including SMC3) preferred the A allele. ChIP qPCR assays showed significant enrichment of CTCF and SMC3 signals at the rs60464856 site with preferential binding to the A allele. To evaluate the potential role of this locus in maintaining long-range chromatin structure, we analyzed a HiC dataset and found that the rs60464856 locus enriched consistent chromatin interactions in prostate cell lines. To determine the potential role of the rs60464856 target gene, we knocked down the RUVBL1 via shRNA and observed significant proliferation inhibition in prostate cell lines. We also tested PC3 cells with RUVBL1 knockdown in nude mice xenografts and observed reduced tumorigenesis. Gene set enrichment analysis showed that RUVBL1 expression was associated with the enrichment of cell cycle related pathways in both cell line and TCGA prostate cancer cohorts. Lastly, we showed that an increased RUVBL1 expression and its relevant pathway activation were associated with poor survival. Conclusion We applied the CRISPR interference screening at selected prostate cancer risk loci and identified over a hundred regulatory SNPs essential for prostate cell proliferation. Further analysis confirmed the important role of rs60464856 and its target gene RUVBL1 in prostate cell growth and tumorigenesis.
To discover proliferative essential SNP loci, we used CRISPRi screening technology and DNA-seq to determine those functional candidate from previously published eQTL variants
|
| |
|
| Overall design |
Guide RNA (gRNA) read count were compared between screening ending and start in two replicates with RIGER program. Differential gene expression analysis were performed to compare the RUVBL1 induced changes
|
| |
|
| Contributor(s) |
Tian Y, Dong D, Wu L, Park J, Wei G, Wang L |
| Citation(s) |
36711639 |
| |
| Submission date |
Feb 06, 2023 |
| Last update date |
Jul 05, 2023 |
| Contact name |
Liang Wang |
| E-mail(s) |
Liang.Wang@Moffitt.org
|
| Phone |
8137454955
|
| Organization name |
Moffitt Cancer Center
|
| Street address |
14059 Riveredge Drove
|
| City |
TAMPA |
| State/province |
FL |
| ZIP/Postal code |
33637 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL33098 |
Illumina HiSeq 2500 (Expression vector lentiGuide-Puro) |
|
| Samples (10)
|
| GSM7029083 |
gRNA readout in DU145, day1, baseline |
| GSM7029084 |
gRNA readout in DU145, day21, replicate1 |
| GSM7029085 |
gRNA readout in DU145, day21, replicate2 |
| GSM7029086 |
gRNA readout in lentiguide puro plasmid library |
| GSM7029087 |
gRNA readout in PC3, day1, baseline |
| GSM7029088 |
gRNA readout in PC3, day21, replicate1 |
| GSM7029089 |
gRNA readout in PC3, day21, replicate2 |
|
| This SubSeries is part of SuperSeries: |
| GSE224654 |
Combined CRISPR and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression |
|
| Relations |
| BioProject |
PRJNA934492 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE224653_gRNA_quantification_rawcount.txt.gz |
334.1 Kb |
(ftp)(http) |
TXT |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...